Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivian Juang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Pharmaceutics|October 23, 2024
Development and optimization of an in vitro release assay for evaluation of liposomal irinotecan formulationVivian Juang, Jingyao Gan, Ziyun Xia, et al.
International Journal of Pharmaceutics|June 27, 2025
In vitro release method development for Onivyde® using Agilent NanoDis® systemJi Li, Vivian Juang, Ziyi Lu, et al.
International Journal of Nanomedicine|November 30, 2016
Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cellsVivian Juang, Hsin-Pin Lee, Anya Maan-Yuh Lin, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 12, 2019
pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific TherapyVivian Juang, Chih-Hsien Chang, Chen-Shen Wang, et al.
Plos One|October 3, 2017
Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsGuan-Liang Lin, Huei-Ju Ting, Ta-Chien Tseng, et al.
International Journal of Pharmaceutics|September 17, 2025
Characterization of Crinone®: progesterone vaginal gelJi Li, Kaikai Wang, Ziyi Lu, et al.
The AAPS Journal|March 14, 2026
Development of an In Vitro Release Test to Characterize Onivyde® Using Bio-Beads SM-2 ResinVivian Juang, May Thazin Phoo, Hsiu-Wei Yang, et al.
International Journal of Pharmaceutics|November 28, 2024
Reverse engineering of Onivyde® - Irinotecan liposome injectionJingyao Gan, Vivian Juang, Kaikai Wang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Pharmaceutics|October 23, 2024
Development and optimization of an in vitro release assay for evaluation of liposomal irinotecan formulationVivian Juang, Jingyao Gan, Ziyun Xia, et al.
International Journal of Pharmaceutics|June 27, 2025
In vitro release method development for Onivyde® using Agilent NanoDis® systemJi Li, Vivian Juang, Ziyi Lu, et al.
International Journal of Nanomedicine|November 30, 2016
Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cellsVivian Juang, Hsin-Pin Lee, Anya Maan-Yuh Lin, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 12, 2019
pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific TherapyVivian Juang, Chih-Hsien Chang, Chen-Shen Wang, et al.
Plos One|October 3, 2017
Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsGuan-Liang Lin, Huei-Ju Ting, Ta-Chien Tseng, et al.
International Journal of Pharmaceutics|September 17, 2025
Characterization of Crinone®: progesterone vaginal gelJi Li, Kaikai Wang, Ziyi Lu, et al.
The AAPS Journal|March 14, 2026
Development of an In Vitro Release Test to Characterize Onivyde® Using Bio-Beads SM-2 ResinVivian Juang, May Thazin Phoo, Hsiu-Wei Yang, et al.
International Journal of Pharmaceutics|November 28, 2024
Reverse engineering of Onivyde® - Irinotecan liposome injectionJingyao Gan, Vivian Juang, Kaikai Wang, et al.
Pageof 1